Copyright Reports & Markets. All rights reserved.

Global Inflammatory Bowel Disease Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Inflammatory Bowel Disease Drugs Market Overview

      • 1.1 Product Overview and Scope of Inflammatory Bowel Disease Drugs
      • 1.2 Inflammatory Bowel Disease Drugs Segment by Type
        • 1.2.1 Global Inflammatory Bowel Disease Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Ulcerative Colitis
        • 1.2.3 Crohns Disease
        • 1.2.4 Indeterminate Colitis
        • 1.2.5 Others
      • 1.3 Inflammatory Bowel Disease Drugs Segment by Application
        • 1.3.1 Inflammatory Bowel Disease Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Amino-salicylates
        • 1.3.3 Antibiotics
        • 1.3.4 Corticosteroids
        • 1.3.5 Immunomodulators
        • 1.3.6 Biologics
        • 1.3.7 Others
      • 1.4 Global Inflammatory Bowel Disease Drugs Market by Region
        • 1.4.1 Global Inflammatory Bowel Disease Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Inflammatory Bowel Disease Drugs Market Size
        • 1.5.1 Global Inflammatory Bowel Disease Drugs Revenue (2014-2025)
        • 1.5.2 Global Inflammatory Bowel Disease Drugs Production (2014-2025)

      2 Global Inflammatory Bowel Disease Drugs Market Competition by Manufacturers

      • 2.1 Global Inflammatory Bowel Disease Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Inflammatory Bowel Disease Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Inflammatory Bowel Disease Drugs Production Sites, Area Served, Product Types
      • 2.5 Inflammatory Bowel Disease Drugs Market Competitive Situation and Trends
        • 2.5.1 Inflammatory Bowel Disease Drugs Market Concentration Rate
        • 2.5.2 Inflammatory Bowel Disease Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Inflammatory Bowel Disease Drugs Production Market Share by Regions

      • 3.1 Global Inflammatory Bowel Disease Drugs Production Market Share by Regions
      • 3.2 Global Inflammatory Bowel Disease Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Inflammatory Bowel Disease Drugs Production
        • 3.4.1 North America Inflammatory Bowel Disease Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Inflammatory Bowel Disease Drugs Production
        • 3.5.1 Europe Inflammatory Bowel Disease Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Inflammatory Bowel Disease Drugs Production (2014-2019)
        • 3.6.1 China Inflammatory Bowel Disease Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Inflammatory Bowel Disease Drugs Production (2014-2019)
        • 3.7.1 Japan Inflammatory Bowel Disease Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Inflammatory Bowel Disease Drugs Consumption by Regions

      • 4.1 Global Inflammatory Bowel Disease Drugs Consumption by Regions
      • 4.2 North America Inflammatory Bowel Disease Drugs Consumption (2014-2019)
      • 4.3 Europe Inflammatory Bowel Disease Drugs Consumption (2014-2019)
      • 4.4 China Inflammatory Bowel Disease Drugs Consumption (2014-2019)
      • 4.5 Japan Inflammatory Bowel Disease Drugs Consumption (2014-2019)

      5 Global Inflammatory Bowel Disease Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Inflammatory Bowel Disease Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Inflammatory Bowel Disease Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Inflammatory Bowel Disease Drugs Price by Type (2014-2019)
      • 5.4 Global Inflammatory Bowel Disease Drugs Production Growth by Type (2014-2019)

      6 Global Inflammatory Bowel Disease Drugs Market Analysis by Applications

      • 6.1 Global Inflammatory Bowel Disease Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Inflammatory Bowel Disease Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Inflammatory Bowel Disease Drugs Business

      • 7.1 Abbott Laboratories
        • 7.1.1 Abbott Laboratories Inflammatory Bowel Disease Drugs Production Sites and Area Served
        • 7.1.2 Inflammatory Bowel Disease Drugs Product Introduction, Application and Specification
        • 7.1.3 Abbott Laboratories Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Biocon Ltd
        • 7.2.1 Biocon Ltd Inflammatory Bowel Disease Drugs Production Sites and Area Served
        • 7.2.2 Inflammatory Bowel Disease Drugs Product Introduction, Application and Specification
        • 7.2.3 Biocon Ltd Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Roche
        • 7.3.1 Roche Inflammatory Bowel Disease Drugs Production Sites and Area Served
        • 7.3.2 Inflammatory Bowel Disease Drugs Product Introduction, Application and Specification
        • 7.3.3 Roche Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Johnson and Johnson
        • 7.4.1 Johnson and Johnson Inflammatory Bowel Disease Drugs Production Sites and Area Served
        • 7.4.2 Inflammatory Bowel Disease Drugs Product Introduction, Application and Specification
        • 7.4.3 Johnson and Johnson Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Mylan Pharmaceuticals
        • 7.5.1 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Production Sites and Area Served
        • 7.5.2 Inflammatory Bowel Disease Drugs Product Introduction, Application and Specification
        • 7.5.3 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Novartis AG
        • 7.6.1 Novartis AG Inflammatory Bowel Disease Drugs Production Sites and Area Served
        • 7.6.2 Inflammatory Bowel Disease Drugs Product Introduction, Application and Specification
        • 7.6.3 Novartis AG Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Pfizer
        • 7.7.1 Pfizer Inflammatory Bowel Disease Drugs Production Sites and Area Served
        • 7.7.2 Inflammatory Bowel Disease Drugs Product Introduction, Application and Specification
        • 7.7.3 Pfizer Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Quest Medical
        • 7.8.1 Quest Medical Inflammatory Bowel Disease Drugs Production Sites and Area Served
        • 7.8.2 Inflammatory Bowel Disease Drugs Product Introduction, Application and Specification
        • 7.8.3 Quest Medical Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Sanofi
        • 7.9.1 Sanofi Inflammatory Bowel Disease Drugs Production Sites and Area Served
        • 7.9.2 Inflammatory Bowel Disease Drugs Product Introduction, Application and Specification
        • 7.9.3 Sanofi Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Takeda Pharmaceutical
        • 7.10.1 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Production Sites and Area Served
        • 7.10.2 Inflammatory Bowel Disease Drugs Product Introduction, Application and Specification
        • 7.10.3 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Inflammatory Bowel Disease Drugs Manufacturing Cost Analysis

      • 8.1 Inflammatory Bowel Disease Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs
      • 8.4 Inflammatory Bowel Disease Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Inflammatory Bowel Disease Drugs Distributors List
      • 9.3 Inflammatory Bowel Disease Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Inflammatory Bowel Disease Drugs Market Forecast

      • 11.1 Global Inflammatory Bowel Disease Drugs Production, Revenue Forecast
        • 11.1.1 Global Inflammatory Bowel Disease Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Inflammatory Bowel Disease Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Inflammatory Bowel Disease Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Inflammatory Bowel Disease Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Inflammatory Bowel Disease Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Inflammatory Bowel Disease Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Inflammatory Bowel Disease Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Inflammatory Bowel Disease Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Inflammatory Bowel Disease Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Inflammatory Bowel Disease Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Inflammatory Bowel Disease Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Inflammatory Bowel Disease Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Inflammatory Bowel Disease Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Inflammatory Bowel Disease Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Inflammatory Bowel Disease Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease.
        The growth in prevalence of inflammatory bowel diseases such as ulcerative colitis and Crohn's disease majorly drives the growth of the market. In addition, increase in intake of unhealthy food and drinks, and sedentary and stressful lifestyle propels the growth of the market. The increase in healthcare expenditure by government and private organizations is anticipated to increase the market growth.

        The global Inflammatory Bowel Disease Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Inflammatory Bowel Disease Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inflammatory Bowel Disease Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Abbott Laboratories
        Biocon Ltd
        Roche
        Johnson and Johnson
        Mylan Pharmaceuticals
        Novartis AG
        Pfizer
        Quest Medical
        Sanofi
        Takeda Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Ulcerative Colitis
        Crohns Disease
        Indeterminate Colitis
        Others

        Segment by Application
        Amino-salicylates
        Antibiotics
        Corticosteroids
        Immunomodulators
        Biologics
        Others

        Buy now